UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini

Journal of pharmacokinetics and pharmacodynamics, 2022-06, Vol.49 (3), p.293-310

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction to: R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini

Journal of pharmacokinetics and pharmacodynamics, 2022-06, Vol.49 (3), p.395-395

2022

Link zum Volltext

Verfügbarkeit prüfen

Determinants in the Envelope E Protein and Viral RNA Helicase NS3 That Influence the Induction of Apoptosis in Response to Infection with Dengue Type 1 Virus

Virology (New York, N.Y.), 2000-09, Vol.274 (2), p.292-308

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

Journal of clinical pharmacology, 2002-08, Vol.42 (8), p.887-898

2002

Link zum Volltext

Verfügbarkeit prüfen

PD4-3-4: Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRs) to clinical study results from western and Japanese patient populations

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S455-S456

2007

Link zum Volltext

Verfügbarkeit prüfen

Bioavailability of orally administered micronised fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39 Suppl 1 (Supplement 1), p.9-15

2000

Link zum Volltext

Verfügbarkeit prüfen

Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers

Clinical pharmacokinetics, 2000, Vol.39 Suppl 1 (Supplement 1), p.1-8

2000

Link zum Volltext

Verfügbarkeit prüfen

Single-Dose and Steady-State Pharmacokinetic and Pharmacodynamic Evaluation of Therapeutically Clinically Equivalent Doses of Inhaled Fluticasone Propionate and Budesonide, Given as Diskus® or Turbohaler® Dry-Powder Inhalers to Healthy Subjects

Journal of clinical pharmacology, 2001-12, Vol.41 (12), p.1329-1338

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

Clinical pharmacokinetics, 2000, Vol.39 Suppl 1 (Supplement 1), p.23-30

2000

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.938-941

1996

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

Clinical pharmacokinetics, 2000, Vol.39 Suppl 1 (Supplement 1), p.31-37

2000

Link zum Volltext

Verfügbarkeit prüfen

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant

Clinical pharmacokinetics, 2000, Vol.39 Suppl 1 (Supplement 1), p.17-22

2000

Link zum Volltext

Verfügbarkeit prüfen

Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler®, Diskus® and metered-dose inhaler in healthy volunteers: The pharmacokinetics of fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39, p.1-8

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

Journal of clinical pharmacology, 2002-08, Vol.42 (8), p.887-898

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in patients with mild-to-moderate asthma: The pharmacokinetics of fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39, p.31-37

2000

Link zum Volltext

Verfügbarkeit prüfen

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant: The pharmacokinetics of fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39, p.17-22

2000

Link zum Volltext

Verfügbarkeit prüfen

Bioavailability of orally administered micronised fluticasone propionate: The pharmacokinetics of fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39, p.9-15

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in healthy volunteers: The pharmacokinetics of fluticasone propionate

Clinical pharmacokinetics, 2000, Vol.39, p.23-30

2000

Link zum Volltext

Verfügbarkeit prüfen

In-Silico Prediction of Drug Properties in Man Using Preclinical Data and Computer-Assisted Drug Development

Therapeutic innovation & regulatory science, 2001-10, Vol.35 (4), p.1047-1063

2001

Link zum Volltext

Verfügbarkeit prüfen

MODELING AND SIMULATION TO PREDICT OPTIMAL DOSES OF A NOVEL FLLORO-QUINOLONE, DC-159a IN HEALTHY SUBJECTS AND SPECIAL POPULATION: 47

Journal of clinical pharmacology, 2008-09, Vol.48 (9), p.1109-1109

2008

Link zum Volltext

Verfügbarkeit prüfen

Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience

European journal of cardio-thoracic surgery, 2013-01, Vol.43 (1), p.111-114

2013

Link zum Volltext

Verfügbarkeit prüfen

Catamenial and Noncatamenial, Endometriosis-related or Nonendometriosis-related Pneumothorax Referred for Surgery

American journal of respiratory and critical care medicine, 2007-11, Vol.176 (10), p.1048-1053

2007

Link zum Volltext

Verfügbarkeit prüfen

Revascularization of the Right Coronary Artery: Grafting or Percutaneous Coronary Intervention?

The Annals of thoracic surgery, 2005-04, Vol.79 (4), p.1232-1239

2005

Link zum Volltext

Verfügbarkeit prüfen

Management of the second episode of spontaneous pneumothorax: a decision analysis

The Annals of thoracic surgery, 2003-12, Vol.76 (6), p.1843-1848

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adult
(10)
Male
(10)
Pharmacology & Pharmacy
(10)
Pharmacology. Drug Treatments
(9)
Respiratory System
(8)
Androstadienes - Pharmacokinetics
(7)
Anti-Asthmatic Agents - Pharmacokinetics
(7)
Cross-Over Studies
(7)
Fluticasone
(7)
Middle Aged
(7)
Administration, Inhalation
(6)
Double-Blind Method
(6)
Adolescent
(5)
Androstadienes - Blood
(5)
Anti-Asthmatic Agents - Blood
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini

Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children

Correction to: R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini

Determinants in the Envelope E Protein and Viral RNA Helicase NS3 That Influence the Induction of Apoptosis in Response to Infection with Dengue Type 1 Virus

Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

PD4-3-4: Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRs) to clinical study results from western and Japanese patient populations

Bioavailability of orally administered micronised fluticasone propionate

Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers

Single-Dose and Steady-State Pharmacokinetic and Pharmacodynamic Evaluation of Therapeutically Clinically Equivalent Doses of Inhaled Fluticasone Propionate and Budesonide, Given as Diskus® or Turbohaler® Dry-Powder Inhalers to Healthy Subjects

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant

Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler®, Diskus® and metered-dose inhaler in healthy volunteers: The pharmacokinetics of fluticasone propionate

Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in patients with mild-to-moderate asthma: The pharmacokinetics of fluticasone propionate

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant: The pharmacokinetics of fluticasone propionate

Bioavailability of orally administered micronised fluticasone propionate: The pharmacokinetics of fluticasone propionate

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in healthy volunteers: The pharmacokinetics of fluticasone propionate

In-Silico Prediction of Drug Properties in Man Using Preclinical Data and Computer-Assisted Drug Development

MODELING AND SIMULATION TO PREDICT OPTIMAL DOSES OF A NOVEL FLLORO-QUINOLONE, DC-159a IN HEALTHY SUBJECTS AND SPECIAL POPULATION: 47

Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience

Catamenial and Noncatamenial, Endometriosis-related or Nonendometriosis-related Pneumothorax Referred for Surgery

Revascularization of the Right Coronary Artery: Grafting or Percutaneous Coronary Intervention?

Management of the second episode of spontaneous pneumothorax: a decision analysis

Suchergebnisse filtern